A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group

Annals of Oncology ◽

10.1093/oxfordjournals.annonc.a059049 ◽

1995 ◽

Vol 6 (1) ◽

pp. 77-79 ◽

Author(s):

M. Di Bartolomeo ◽

E. Bajetta ◽

A.M. Bochicchio ◽

C. Carnaghi ◽

L. Somma ◽

...

Keyword(s):

Phase Ii ◽

Neuroendocrine Tumours ◽

Medical Oncology ◽

Download Full-text

Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO)

Breast Cancer Research and Treatment ◽

10.1007/s10549-019-05259-z ◽

2019 ◽

Vol 176 (3) ◽

pp. 607-615

Author(s):

Christel Fontaine ◽

Vincent Renard ◽

Heidi Van den Bulk ◽

Peter Vuylsteke ◽

Philip Glorieux ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Medical Oncology ◽

Phase Ii Trial ◽

Belgian Society ◽

Prospective Phase

Download Full-text

608P METNET: A phase II trial of metformin in patients with well differentiated neuroendocrine tumours

Annals of Oncology ◽

10.1016/j.annonc.2020.08.468 ◽

2020 ◽

Vol 31 ◽

pp. S505-S506

Author(s):

J. Glasberg ◽

T. Giollo Rivelli ◽

A. Talans ◽

R. Mendoza Lopez ◽

J.E. Bezerra Neto ◽

...

Keyword(s):

Phase Ii ◽

Neuroendocrine Tumours ◽

Phase Ii Trial ◽

Well Differentiated

Download Full-text

Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma. Daliani DD, Assikis V, Tu SM, Papandreou CN, Pagliaro LC, Holtkamp T, Wang X, Thall PF, Logothetis CJ, Department of Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Urologic Oncology Seminars and Original Investigations ◽

10.1016/s1078-1439(03)00116-9 ◽

2003 ◽

Vol 21 (5) ◽

pp. 412

Author(s):

Donald L Trump

Keyword(s):

Phase Ii ◽

Prostate Carcinoma ◽

Medical Oncology ◽

Phase Ii Trial ◽

Cancer Center ◽

University Of Texas ◽

The University ◽

Androgen Independent

Download Full-text

1122TiP A phase II trial to evaluate the safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor (SSTR)-positive gastroenteropancreatic neuroendocrine tumours (GEP-NETs), pheochromocytomas and paragangliomas (PPGLs)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.204 ◽

2021 ◽

Vol 32 ◽

pp. S920

Author(s):

M.N. Gaze ◽

M.S. O'Dorisio ◽

C. Sábado ◽

F. Brouri ◽

I. Folitar

Keyword(s):

Phase Ii ◽

Neuroendocrine Tumours ◽

Phase Ii Trial ◽

Somatostatin Receptor ◽

Adolescent Patients ◽

Gastroenteropancreatic Neuroendocrine Tumours

Download Full-text

SUNitinib with EVOfosfamide (TH-302) for G1/G2 metastatic pancreatic neuroendocrine tumours (pNETs) naïve for systemic treatment. The SUNEVO phase II trial of the Spanish task force group for neuroendocrine and endocrine tumours (GETNE)

Annals of Oncology ◽

10.1093/annonc/mdz256.004 ◽

2019 ◽

Vol 30 ◽

pp. v566

Author(s):

E. Grande ◽

C. Lopez ◽

T. Alonso Gordoa ◽

M. Benavent ◽

J. Capdevila ◽

...

Keyword(s):

Phase Ii ◽

Neuroendocrine Tumours ◽

Phase Ii Trial ◽

Systemic Treatment ◽

Endocrine Tumours ◽

Pancreatic Neuroendocrine Tumours

Download Full-text

1400: A Randomized Phase II Trial Evaluating the Importance of Early Erectile Dysfunction Rehabilitation and Unilateral Autologous Sural Nerve Grafting in Patients Undergoing a Unilateral Cavernous Nerve Sparing Radical Prostatectomy for Clinically localized PR

The Journal of Urology ◽

10.1016/s0022-5347(18)31601-x ◽

2007 ◽

Vol 177 (4S) ◽

pp. 461-461 ◽

Author(s):

Christopher G. Wood ◽

David Chang ◽

Run Wang ◽

Yu Shen ◽

Curtis A. Pettaway ◽

...

Keyword(s):

Erectile Dysfunction ◽

Radical Prostatectomy ◽

Phase Ii ◽

Sural Nerve ◽

Phase Ii Trial ◽

Nerve Sparing ◽

Nerve Grafting ◽

Cavernous Nerve ◽

Randomized Phase Ii

Download Full-text

1326: Phase II Trial of Gemcitabine, Paclitaxel, and Cisplatin in Advanced Transitional Cell Carcinoma

The Journal of Urology ◽

10.1016/s0022-5347(18)35471-5 ◽

2005 ◽

Vol 173 (4S) ◽

pp. 360-360

Author(s):

Peter E. Clark ◽

Diana Stindt ◽

M. Craig Hall ◽

Michele Harmon ◽

James F. Lovato ◽

...

Keyword(s):

Transitional Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Transitional Cell

Download Full-text

Experimental Drug Shows Activity Against Advanced Ovarian Cancer in Phase II Trial

Ob Gyn News ◽

10.1016/s0029-7437(07)70576-1 ◽

2007 ◽

Vol 42 (13) ◽

pp. 2

Author(s):

PATRICE WENDLING

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Experimental Drug

Download Full-text

Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: A Gynecologic Oncology Group study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70331-2 ◽

2007 ◽

Vol 2007 ◽

pp. 82-83

Author(s):

J.T. Thigpen

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Weekly Paclitaxel ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

Axitinib Shrinks Thyroid Cancer in Phase II Trial

Internal Medicine News ◽

10.1016/s1097-8690(07)70861-2 ◽

2007 ◽

Vol 40 (14) ◽

pp. 22

Author(s):

JANE SALODOF MACNEIL

Keyword(s):

Thyroid Cancer ◽

Phase Ii ◽

Download Full-text